Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q2 2024 Earnings

16MayConfirmed

Q4 2023

Q2 2024

-3.55

-2.56

-1.58

-0.59

Details

Expected EPS

-1.115

Actual EPS

-3.55

Surprise EPS

-2.43

Surprise Percent

+218.39%

Description

Contineum Therapeutics (CTNM) has reported earnings of -3.55 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.